Cincinnati public company to be acquired in $1.53B blockbuster deal

Meridian Bioscience Logo

One of Greater Cincinnati’s largest public companies is set to be acquired by a pair of East Asian firms in a deal worth more than $1.5 billion.

Meridian Bioscience (NASDAQ: VIVO), a provider of diagnostic testing and life science raw materials, said Thursday it has entered into agreement to be acquired by South Korea-based SD Biosensor and SJL Partners for $1.53 billion cash.

Click here to read the complete story.

Story excerpt provided by Cincinnati Business Courier.

Written by Liz Engel.

Originally published July 7, 2022.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: